Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Genentech Inc. published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 56
» View wsbt.com items only
    May 13, 2012 |Story| AP Broadcast

  1. Facebook CEO turns 28: Does age matter?

    NEW YORK (AP) — Don't let the hoodie and sneakers fool you. Mark Zuckerberg is no wet-behind-the-ears CEO. Facebook's chief executive turns 28 on Monday, setting in motion the social network's biggest week ever. The company is expected to start...

    Tags: Apple Inc., University of California, Berkeley, Michael S. Dell, Social Media, Media Industry

    2. Nov 15, 2011 |Story| AP Broadcast

  2. Apple names Arthur Levinson chairman

    CUPERTINO, Calif. (AP) — Apple has named board member Arthur Levinson as its chairman. He fills a vacancy left open when Apple co-founder Steve Jobs died last month. Levinson, who is chairman of Genentech Inc., has been co-lead director on Apple...

    Tags: Steve Jobs, The Walt Disney Co.

    3. Jun 6, 2011 |Story| WSBT-TV

  3. Cancer-fighting pill shows promise in battle against melanoma

    <span style="font-size: small;">MISHAWAKA--- Doctors say a cancer-fighting pill shows promising signs in the fight against melanoma -- the most deadly form of skin cancer. </span>
    MISHAWAKA--- Doctors say a cancer-fighting pill shows promising signs in the fight against melanoma -- the most deadly form of skin cancer. A local oncologist says drug is not a cure, but it shrank tumors and patients who used the drug lived longer....

    Tags: Human Interest, Chemotherapy, Human Body, Physical Conditions, Food and Drug Administration

    4. Jun 13, 2013 |Story| Reuters

  4. As top court invalidates some gene patents, biotech has moved on

    Reuters
    By Sharon Begley NEW YORK, June 13 (Reuters) - The U.S. Supreme Court decision on Thursday to uphold patent protections for genetic material that has been changed in the laboratory but invalidate patents for purely natural DNA may seem like a partial...

    Tags: U.S. Supreme Court, Patents, Copyrights and Trademarks, Pharmaceuticals, GlaxoSmithKline PLC, Chemical Industry

    5. May 12, 2013 |Story| Los Angeles Times

  5. Bill would regulate 'biosimilar' drugs

    SACRAMENTO &mdash; Two of the nation's largest biotech companies &mdash; Amgen Inc. of Thousand Oaks and Genentech Inc. of South San Francisco &mdash; are fighting in Sacramento to keep a tight grip on some of their most lucrative drugs.
    SACRAMENTO — Two of the nation's largest biotech companies — Amgen Inc. of Thousand Oaks and Genentech Inc. of South San Francisco — are fighting in Sacramento to keep a tight grip on some of their most lucrative drugs. At stake is a...

    Tags: Exports, Viral Diseases and Infections, Pharmaceuticals, Amgen Inc., Chemical Industry

    6. Apr 24, 2013 |Story| Chicago Tribune

  6. Boeing, billionaire Penny Pritzker among Obama's donors

    Illinois donors to President Barack Obama&rsquo;s second inauguration included aviation giant Boeing Co., which contributed $1 million, and billionaire Penny Pritzker, who gave $250,000, according to newly filed records.
    Tribune reporter
    Illinois donors to President Barack Obama’s second inauguration included aviation giant Boeing Co., which contributed $1 million, and billionaire Penny Pritzker, who gave $250,000, according to newly filed records. Pritzker, who is being vetted by...

    Tags: Elections, Restaurant and Catering Industry, Bill Enyart, Entertainment, Economy, Business and Finance

    7. Mar 29, 2013 |Story| Los Angeles Times

  7. Remove Medicare's straitjacket

    Now that the budget "sequester" is in effect, Congress is shifting its attention to entitlement reform. There's simply no way to achieve long-term reductions in federal spending without touching the big health programs, particularly Medicare. Although raising the age of Medicare eligibility from 65 to 67 appears off the table, at least for now, the budget plan that Rep. Paul D. Ryan (R-Wis.) is proposing would shift a greater share of the program's growing costs to beneficiaries in the years to come.
    Now that the budget "sequester" is in effect, Congress is shifting its attention to entitlement reform. There's simply no way to achieve long-term reductions in federal spending without touching the big health programs, particularly Medicare. Although...

    Tags: Pharmaceuticals, Medicare, Marketing, Chemical Industry, U.S. Congress

    8. Feb 19, 2013 |Story| Reuters

  8. Almost one-third of chemotherapy used 'off-label'

    NEW YORK (Reuters Health) - About one-third of chemotherapies are used to fight cancers that drug regulators never approved them to treat, says a new study.
    Reuters
    NEW YORK (Reuters Health) - About one-third of chemotherapies are used to fight cancers that drug regulators never approved them to treat, says a new study. Chemotherapies - drugs that kill rapidly dividing cells - are approved by the Food and Drug...

    Tags: Chemotherapy, Harvard Medical School, Health Treatments, Food and Drug Administration, Science and Technology

    9. Jan 14, 2013 |Story| Los Angeles Times

  9. Inaugural fundraisers race to meet $50-million goal

    <span class="runtimeTopic">WASHINGTON</span> &mdash; With less than a week to go before President Obama is sworn in for his second term, fundraisers for the presidential inaugural committee were still working Monday to secure their goal of $50 million in private donations to finance the official festivities.
    WASHINGTON — With less than a week to go before President Obama is sworn in for his second term, fundraisers for the presidential inaugural committee were still working Monday to secure their goal of $50 million in private donations to finance the...

    Tags: Festive Events, Microsoft Corporation, Centene Corporation, Federal Election Commission, Finance

    10. Mar 17, 2013 |Story| Los Angeles Times

  10. Battle over 'biosimilars'

    One of the most promising frontiers in healthcare is biologic medicines &mdash; complex substances derived from living cells that can help fight chronic diseases and cancers. To encourage investment in biologics, Congress in 2010 gave drug companies what amounts to a 12-year monopoly on the substances they developed. Now, supporters of biologics are pushing lawmakers in Sacramento and other state capitals to put new hurdles in the way of knock-off compounds, called "biosimilars."
    One of the most promising frontiers in healthcare is biologic medicines — complex substances derived from living cells that can help fight chronic diseases and cancers. To encourage investment in biologics, Congress in 2010 gave drug companies...

    Tags: General Practitioners, Pharmaceuticals, Chemical Industry, U.S. Congress, Biotechnology Industry

    11. Mar 6, 2013 |Story| Los Angeles Times

  11. Facebook is about to redesign News Feed: Here's what to expect

    SAN FRANCISCO -- Facebook is rolling out a radical new redesign of News Feed, the biggest since it launched the feature in 2006.
    SAN FRANCISCO -- Facebook is rolling out a radical new redesign of News Feed, the biggest since it launched the feature in 2006. The giant social network plans to unveil the redesign at a press conference Thursday at its Menlo Park, Calif.,...

    Tags: Companies and Corporations, Corporate Officers, Social Media, Marketing, Media Industry

    12. Mar 3, 2013 |Story| Baltimore Sun

  12. Asthma drug calms chronic hives, rashes

    Sufferers of chronic hives and rashes could benefit from a commonly-used asthma drug, Johns Hopkins researchers have found. Scientists found that a once-a-month dose of the drug omalizumab helped ease symptoms that standard antihistamines didn't....

    Tags: Novartis AG, Asthma, Skin Rash, Symptoms, Medical Research

 1  2 3 4 5 • Next >
Original site for Genentech Inc. topic gallery.
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
Genentech Inc. Photos
Some firms seek to make "biosimilar" drugs that would p...
(April 25, 2013)
Bill would regulate &#8216;biosimilar&#8217; drugs
Dr. Jeffrey Bloss has joined Astellas US LLC as vice pr...
(November 28, 2012)
Dr. Jeffrey Bloss, vice president of scientific and medical affairs, Astellas US LLC
Lisa Harris Jones, of the firm Harris Jones Malone, has...
(March 20, 2003)
No. 3: Lisa Harris Jones